PubMed Health⌕ Search

PubMed · 16226021

Lumbar spine intersegmental motion analysis during lifting.

Abstract

UNLABELLED: There are a lot of in vitro and also in vivo studies under strictly restricted and subject-demanding laboratory conditions using X-ray or MRI recordings, but very few studies give information about the lumbar spine intersegmental behavior in daily life activities. Aims of this study were to measure the intersegmental lumbar spine motions during lifting trials and to determine the different motion patterns of different subjects performing comparable lifting tasks. First, 11 healthy volunteers had to perform lifting tasks (box weight 4-15 kg) using their favorite lifting technique (no instructions by the researcher). The coordinates of skin-markers attached on lumbar spines of the subjects were measured using 3D-motion capturing and then transformed to Cardan-angles. Second, 23 volunteers performed lifting tasks (box weight 4-15 kg) with the instruction to bend their knees during lifting. Coordinates of this smaller set of markers on lumbar spines of the subjects were transformed to intersegmental angles using a spline-method. From the first experiment three groups of motion patterns are distinguishable: subjects who used only small intersegmental range of motion within their upper lumbar spine and bended their knees during lifting were in contrast to subjects who used 3.25 times wider range of motion in the upper lumbar spine and did not bend the knees (cluster analysis, c = 0.76). The third group was not assignable to these other two groups. Within all lifting trials of the second experiment different groups were detectable also: in spite of all subjects bended their knees, there were subjects with wide range of motion of lumbar spine motion segments. Other subjects were able to reduce intersegmental range of motion (k-means clustering, msv > 0.47). From this it follows that the intersegmental motion of lumbar spine is individually different and not equal for all lumbar levels. Furthermore, lifting technique influenced the motion of the lumbar spine. But not for all subjects, the advice to bend the knees during the lifting effectively reduced the lumbar motion ranges. IN CONCLUSION: special instructions to reduce lumbar spinal motion are recommended. Due to different lumbar spine motion patterns, different loading situations are anticipated because of changing lever arms and angular accelerations. This understanding is important in reducing spinal loading and to prevent spinal disorders in manual material handling tasks.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Falk Mörl, Heiko Wagner, Reinhard Blickhan. 2005-10-12. Lumbar spine intersegmental motion analysis during lifting.. https://doi.org/10.1016/j.pathophys.2005.09.003

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗